{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"104"},{"groupId":"OG001","value":"98"}],"units":"Participants"}],"groups":[{"description":"Busulfan with a target daily area under the curve (AUC) of 5000 with Melphalan 70 mg/m2 followed by a stem cell transplant","id":"OG000","title":"Busulfan + Melphalan"},{"description":"High-dose Melphalan 200 mg/m2/day followed by a stem cell transplant","id":"OG001","title":"Melphalan"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"100 days post treatment","title":"Treatment-Related Mortality (TRM) Between 2 Arms.","type":"SECONDARY","unitOfMeasure":"Participants"}